- Open Access
Exotic glycerol dehydrogenase expressing Escherichia coli increases yield of 2,3-butanediol
Bioresources and Bioprocessing volume 5, Article number: 3 (2018)
The thriving of biodiesel industry has led to produce 10% (v/v) crude glycerol, thus creating an overflow problem. Biofuel production is restricted by Escherichia coli due to its toxicity to bacterial cells. Therefore, a platform chemical and fuel additive 2,3-butanediol (2,3-BD) with low toxicity to microbes could be a promising alternative for biofuel production by recombinant E. coli using glycerol as the sole substrate.
A novel expression system of E. coli was developed to express the dhaD gene encoding glycerol dehydrogenase (GDH) to produce value-added metabolic products through aerobic biotransformation of glycerol. The dhaD gene obtained from Klebsiella pneumoniae SRP2 was expressed in E. coli BL21(DE3)pLysS using an E. coli–K. pneumoniae shuttle vector pJET1.2/blunt consisting of chloramphenicol-resistance gene under the control of the T7lac promotor. RT-PCR analysis and dhaD overexpression confirmed that the 2,3-BD synthesis pathway gene was expressed on RNA and protein levels. Therefore, the recombinant E. coli exhibited a 38.9-fold higher enzyme activity (312.57 units/mg protein), yielding 8.97 g/L 2,3-BD, a 2.4-fold increase with respect to the non-recombinant strain.
The engineered strain E. coli BL21(DE3)pLysS/pJET1.2/blunt-dhaD, carrying the 2,3-BD pathway gene dhaD from our newly isolated Klebsiella pneumoniae SRP2 strain, displayed the best ability to synthesize 2,3-BD from low-cost biomass glycerol. The value of expression of an important glycerol metabolism gene dhaD is the highest ever achieved with an engineered E. coli strain. From these results, the first reported dhaD expression system has paved the way for improvement of 2,3-BD production and is efficient for another heterologous gene expression in E. coli.
With increasing fossil fuel price and environmental concern, alternative and renewable energy sources have become attractive. Biodiesel, a renewable and promising combustion fuel, is synthesized from vegetable oils and animal fats. However, the biodiesel synthesis process (transesterification) generates 10% crude glycerol as a core by-product which is the cheapest feedstock or negative-value biomass to produce a high-value green product, 2,3-BD (Rahman et al. 2015). 2,3-BD is an important platform chemical, and it is also known as an excellent building block in the synthesis of valuable chiral chemicals (Celinska and Grajek 2009; Zeng and Sabra 2011). Chemical biosynthesis processes for the production of optically pure 2,3-BD are difficult to control, complicated and expensive. Thus, the biotransformation process has been considered as the preferred method for the production of optically pure 2,3-BD (Celinska and Grajek 2009; Ji et al. 2011; Zeng and Sabra 2011). Several engineered strains of microorganisms including Saccharomyces cerevisiae, Enterobacter cloacae, Bacillus licheniformis and E. coli have been used for the production of optically pure 2,3-BD (Yan et al. 2009; Lian et al. 2014; Li et al. 2015; Wang et al. 2012).
In the past few years, several microorganisms including cyanobacteria, fungi and bacteria have been proved to produce biofuels and fuel additives using different biomasses (Domínguez de María 2011; Gross 2012; Yan et al. 2009]. E. coli is extensively used as a model organism for biofuel production using pentose and hexose sugars from lignocellulosic biomass (Bokinsky et al. 2011). Now, it has been proved that recombinant E. coli can produce numerous biofuels including ethanol, acetone, butanol, α-pinene, isoprenol, isobutanol and fatty alcohols through biosynthetic pathways (Bokinsky et al. 2011; May et al. 2013; Atsumi et al. 2008; Zhang et al. 2013; Yang et al. 2013). Nevertheless, these biofuels are highly toxic to E. coli, and the production of new end products which are less or non-toxic to microbial cells is needed to obtain high product yield (Baez et al. 2011) using low-cost or negative-cost biomass. Thus, less toxic metabolic products such as 2,3-BD, 1,3-propanediol (1,3-PDO) and acetoin can be produced through biotechnological routes (Ji et al. 2011). Moreover, an industrially important platform chemical 2,3-BD could be produced through the oxidative pathway of recombinant E. coli (Xu et al. 2007). A high heating value (27,200 J/g) bulk chemical 2,3-BD could be used as liquid fuel or fuel additive (Xiao et al. 2012); it has very low toxicity to bacterial cells (Oliver et al. 2013). Therefore, 2,3-BD could be a promising alternative for biofuel production through recombinant E. coli strains.
Several bacterial species including Klebsiella pneumoniae, K. variicola, K. oxytoca, Serratia marcescens and Enterobacter cloacae have been used to produce 2,3-BD with high yields through optimization of culture conditions or genetic engineering (Celinska and Grajek 2009; Kim et al. 2013), but these strains are pathogenic or opportunistic pathogens and have been categorized under risk group-2 microorganisms, unsuitable for industrial-scale biotransformation (Ji et al. 2011; Kim et al. 2013). The microorganisms that may cause disease in humans and animals but are unlikely to be a serious hazard to laboratory personnel, the community, animals or the environment are called risk group 2. However, the strain E. coli BL21(DE3)pLysS has been known to be non-pathogenic and does not carry any virulence factor or pathogenic mechanism causing infections (Chart et al. 2000). Consequently, E. coli BL21(DE3)pLysS strain could be the best candidate for the safe synthesis of bioproducts (Chart et al. 2000; Zhang et al. 2013). Therefore, in this research work, a preliminary attempt has been made to establish a method for 2,3-BD production efficiently using E. coli BL21(DE3)pLysS. Moreover, in the oxidative pathway of glycerol metabolisms, there are three key enzymes, viz., glycerol dehydrogenase (GDH), α-acetolactate synthase and acetoin reductase which are involved in 2,3-BD biosynthesis (Celinska and Grajek 2009; Zhang et al. 2013). Consequently, GDH is the first enzyme in the oxidative pathway for converting glycerol to dihydroxyacetone(DHA), and then 2,3-BD is produced through pyruvate (Rahman et al. 2015) (Fig. 1). Several works have been reported on the production of 2,3-BD by recombinant E. coli through metabolic engineering of the genes, budB and budC, responsible for α-acetolactate synthase and acetoin reductase enzymes, respectively (Li et al. 2012), but there is no report on the dhaD gene in the same pathway which is responsible for GDH enzyme production. Therefore, it is important to construct an efficient 2,3-BD biosynthesis pathway that includes the related gene cluster to improve 2,3-BD production. In this backdrop, our aim was to construct a novel dhaD expression system in E. coli and its application for 2,3-BD production under completely aerobic condition. In this work, a systematic approach has been taken to construct and optimize 2,3-BD production by an efficient engineered E. coli BL21(DE3)pLysS strain. This research work is the first step for systematic metabolic engineering, which we successfully made as the novel expression system of the dhaD gene, and a high enzyme activity (GDH) was achieved through batch biotransformation process using glycerol as the sole carbon source.
Enzymes and chemicals
2,3-Butanediol (99.0%) was purchased from Sigma Aldrich (Canada). The restriction enzymes, Fast Pfu DNA polymerase and T4 DNA ligase, were purchased from Thermo Fisher Scientific, Canada. Isopropyl-β-d-thiogalactoside (IPTG), ampicillin and chloramphenicol were purchased from BioShop, Canada. All other chemicals used in this research work were analytical-grade reagents and commercially available.
Bacterial strains and vector
Newly isolated K. pneumoniae SRP2 was used for isolation and amplification of the dhaD gene. E. coli JM109 and E. coli BL21(DE3)pLysS strains were used as the hosts for gene cloning and expression, respectively. E. coli BL21(DE3)pLysS was also used as a host strain for 2,3-BD production. Cloning vector pJET1.2/blunt (Thermo Fisher Scientific, Canada) and E. coli BL21(DE3)pLysS contained ampicillin- and chloramphenicol-resistant genes, respectively.
Media and growth conditions
Klebsiella pneumoniae SRP2 and E. coli JM109 were grown in a Luria–Bertani (LB) medium containing (g/L): peptone 10.0 g/L, yeast extract 5.0 g/L and sodium chloride 5.0 g/L. The LB broth medium was supplemented with 100 μg/mL ampicillin and 100 μg/mL ampicillin plus 34 μg/mL chloramphenicol for E. coli JM109 and E. coli BL21(DE3)pLysS/dhaD, respectively, when necessary to maintain the plasmids. For biotransformation or expression study of E. coli BL21(DE3)pLysS/dhaD, MS-2 medium (K2HPO4 0.1 g/L, NaNO3 0.1 g/L, MgSO4.7H2O 0.05 g/L, KCl 0.1 g/L, yeast extract 2.5 g/L and peptone 5.0 g/L) supplemented with 25.0 g/L glycerol, 100 μg/mL ampicillin and 34 μg/mL chloramphenicol was used. The initial pH of the medium was adjusted to 7.0 by adding NaOH/HCl. The biotransformation was carried out in a 250-mL flask containing 50.0 mL medium with 5.0 mL seed culture using a rotary shaker incubator at 200 rpm and 37 °C under aerobic condition. All the seeds and culture media of the E. coli BL21(DE3)pLysS/dhaD were supplemented with ampicillin (100 μg/mL) and chloramphenicol (34 μg/mL) to maintain the plasmid.
Construction of plasmid with the dhaD gene
The dhaD gene encoding glycerol dehydrogenase was amplified through PCR using K. pneumoniae SRP2 genomic DNA as the template. The primers used in PCR were: forward primer—GGATCCATGCGCACTTATTTGAGGGTGA (with BamH1 restriction site) and reverse primer—AAGCTTACGCGCCAGCCACTGGCCT (with HindIII restriction site). The PCR conditions were as follows: initial denaturation at 94 °C for 3 min; then 30 cycles of 30 s at 94 °C, 30 s at 58 °C and 1 min at 72 °C; and final extension at 72 °C 10 min. The amplified product was ligated into cloning vector pJET1.2/blunt at the PCR product site and transferred into E. coli JM109 using calcium chloride heat shock method (Ausubel et al. 1987), resulting in a recombinant plasmid designated as pJET1.2/blunt-dhaD. The ampicillin-resistant colonies were selected on the LB agar plate supplemented with 100 μg/mL ampicillin and purified. However, the plasmid containing the dhaD gene was extracted from E. coli JM109, purified and transferred to the competent cell of E. coli BL21(DE3)pLysS using calcium chloride heat shock method (Ausubel et al. 1987). The recombinant E. coli BL21(DE3)pLysS/pJET1.2/blunt-dhaD designated as E. coli BL21(DE3)pLysS/dhaD was obtained using the heat shock transformation method (Ausubel et al. 1987).
Expression and SDS-PAGE analysis of dhaD
The transformed E. coli BL21(DE3)pLysS containing plasmid pJET1.2/blunt-dhaD was grown at 37 °C in LB medium supplemented with 100 μg/mL ampicillin and 34 μg/mL chloramphenicol for 24 h with shaking at 200 rpm. This overnight culture was inoculated into fresh LB medium containing antibiotics to an OD600 of 0.05–0.1 (1:50 dilution of the overnight culture). One set of glycerol stock culture was stored at − 80 °C until the clone that best expressed the targeted protein was obtained. The cultures were grown until they reach mid-log phase (OD600 = 0.4–0.5, 2–3 h). Subsequent incubation, the cultures were induced by adding IPTG to a final concentration of 0.5 mM, and incubated for an additional 2–4 h, took time points to analyze for optimal expression of targeted protein. Clones were then used for enzymatic assay to determine which clone best expressed the protein of interest. Cells were harvested after 4–7 h of incubation and resuspended in 100 mM potassium phosphate buffer containing 50 mM KCl, sonicated at 4 °C for 2 min (10 s at a time, and until 2 min) and centrifuged (3–5 min at 15,000×g). The supernatant was kept at low temperature (4 °C) and used for protein and GDH enzyme assays. The protein samples were separated by SDS-PAGE using 12% (w/v) SDS-polyacrylamide gel and identified by staining with Coomassie Brilliant Blue R-250 (Merck). SDS-PAGE analysis was carried out using the Laemmli method (Laemmli 1970). The SDS-PAGE analysis was performed on the Mini-PROTEAN Tetra System Electrophoresis (Bio-Rad, Canada). The Broad Range Protein Molecular Marker (Fermentas) was used to estimate the molecular weight of proteins.
Expression: RT-PCR analysis and enzyme assay
To study the expression of the dhaD gene responsible for glycerol utilization in IPTG-induced strain E. coli BL21(DE3)pLysS/dhaD, the experiment was carried out with quantitative real-time polymerase chain reaction (qRT-PCR). Total RNA was extracted using the PureLink™ RNA extraction kit (Ambion, Thermo Fisher Scientific, USA), following the manufacturer’s instructions. The expression of the dhaD gene was evaluated via qRT-PCR. First-strand cDNA was prepared by reverse transcription using the cDNA synthesis kit (Tetro cDNA synthesis Kit, Bioline, UK) in which RNA was used as a template. Quantitative gene expression was carried out using SensiFAST™ SYBR No-ROX Kit (Bioline, UK) on C1000™ thermal cycler quantitative real-time PCR (qRT-PCR) detector system (Bio-Rad, USA). The 16S rRNA obtained based on the primers 5′-GCGGTTGTTACAGTCAGATG-3′ and 5′-GCCTCAGCGTCAGTATCG-3′ was used as an internal standard. The 2−ΔΔCTmethod was used to analyze the fold change gene expression over the control (Lival and Schmittgen 2001).
However, the intracellular GDH activity was determined at room temperature by measuring the reduction of NAD+ to the substrate-dependent absorbance change of NAD(H) at 340 nm (ε340 = 6.22 mM−1 cm−1) using the method described by Ahrens et al. (1998) with slight modification (Rahman et al. 2015). Briefly, 1 mL of the reaction mixture contains 50 mM potassium phosphate buffer (pH 8.0), 30 mM ammonium sulfate, 0.2 M glycerol and 1.2 mM NAD. The assay was initiated by adding 50 µL of cell extract in 250 µL reaction mixture, and the absorbance increase (NADH) was observed from the spectrophotometer for 2–3 min. One unit of activity is the amount of enzyme required to reduce 1 µmol of substrate per minute. The specific activity of GDH is expressed as μmol of substrate reduced/min/mg of cell protein, and represents the averages for at least three cell preparations. The Bradford method was used for the determination of protein concentration (Bradford 1976) and bovine serum albumin served as the standard protein.
The biomass concentration was measured from absorbance at 600 nm. The optical density at 600 nm (OD600) was obtained from a microplate spectrophotometer (EPOCH, BioTek). The metabolic product was identified by GC–MS (Varian 1200 Quadrupole). The concentrations of major metabolic product 2,3-BD, as well as glycerol, were quantified using a GC–FID (Shimatzu GC 14A) under the following conditions: sample volume 1 µL; column temperature range from 45 °C (2 min) to 240 °C at the rate of 10 °C min−1; the injector and detector temperature 250 °C; carrier gas, nitrogen; column, DB-WAXetr. The injecting sample was purified by centrifugation (Fisher Scientific, Germany, accu Spin Micro 17), and membrane filter (0.22 μm pore size), respectively.
All the experiments were performed in triplicate and the results expressed in terms of mean ± SD (standard deviation). The statistical analysis of data was performed to test the significant difference by one-way analysis of variance (ANOVA) followed by Tukey’s honest significant difference (HSD) test (p < 0.05).
Results and discussion
Construction of plasmid with the dhaD gene
The vector pJET1.2/blunt was used for cloning the dhaD gene encoding glycerol dehydrogenase (GDH). After ligation of the amplified product (dhaD) into the cloning vector pJET1.2/blunt, the vector was transferred into E. coli JM109, resulting in recombinant E. coli JM109/pJET1.2/blunt-dhaD (Fig. 2). The ampicillin-resistant colonies were selected from LB agar plates supplemented with 100 μg/mL ampicillin and purified. For the confirmation of dhaD, the plasmid was extracted from transformed E. coli JM109/pJET1.2/blunt-dhaD strain. Transformation of the plasmid containing the dhaD gene into E. coli JM109 was confirmed by agarose gel electrophoresis analysis (Fig. 3). The size of 1125 bp of the dhaD gene, amplified by PCR from the vector (plasmid) using dhaD gene primers (forward and reverse primers), was also confirmed by sequencing.
Clone selection of engineered E. coli BL21(DE3)pLysS/dhaD strains
However, for selection of the best clone, totally six transformed E. coli BL21(DE3)pLysS/dhaD clones were tested for their GDH enzyme activity after 3 h of IPTG induction. All the six clones were almost identical in their enzyme activities, and one of the clones exhibited the highest activity of GDH which was 312.57 U/mg protein (Table 1). Thus, this clone was finally selected for the expression study, nominated as E. coli BL21(DE3)pLysS/dhaD strain. Therefore, this recombinant stain E. coli BL21(DE3)pLysS/dhaD also exhibited the highest biomass production (OD600 = 1.27) compared to that of non-recombinant E. coli BL21(DE3)pLysS and K. pneumoniae SRP2 (Table 1).
However, to confirm that the dhaD gene had inserted into E. coli BL21(DE3)pLysS, agarose gel electrophoresis analysis and gene sequencing were performed. The open reading frame (ORF) of dhaD gene was 1125 bp (Fig. 4). Also, the correct size of 1125 bp of the PCR product (dhaD gene), obtained from the recombinant vector containing the dhaD gene using forward and reverse primers, was confirmed by sequencing.
To compare the expression levels of non-recombinant E. coli BL21(DE3)pLysS, recombinant E. coli BL21(DE3)pLysS/dhaD and a wild-type K. pneumoniae SRP2 strains after induced IPTG (0.5 mM), GDH enzyme activities were determined in vitro. As shown in Fig. 5, when the GDH-expressing plasmid pJET1.2/blunt-dhaD was introduced into E. coli BL21(DE3)pLysS, the resultant strain E. coli BL21(DE3)pLysS/dhaD displayed a significant increase in GDH activity which was 312.57 U/mg protein, 38.9 times more than that of E. coli BL21(DE3)pLysS and 9.99 times more than wild-type strain K. pneumoniae SRP2 (Fig. 5a and Table 1). Similarly, the overexpression of the GDH gene in E. coli BL21(DE3)pLysS did not lead to a significantly enhanced GDH activity after induction with IPTG (Fig. 5a). Moreover, the recombinant GDH was not only highly induced by different concentrations of IPTG, but also markedly stimulated at 37 °C incubation temperature (Fig. 5c). Consequently, at an incubation temperature of 37 °C, the highest intracellular GDH activity was obtained using 0.5 mM IPTG (Fig. 5c). Similar effects had been observed previously in Gluconobacter oxydans MF1 when the gene coding for glucose dehydrogenase or gluconate-5-dehydrogenase was overexpressed (Merfort et al. 2006).
Moreover, the GDH enzyme activity was evaluated with the strain E. coli BL21(DE3)pLysS and its plasmid containing strain E. coli BL21(DE3)pLysS/dhaD, and was found to be on average 38.9.00-fold increased in E. coli BL21(DE3)pLysS/dhaD, which was directly correlated with an increase in the expression of GDH from plasmid pJET1.2/blunt. As shown in Fig. 5a, b, the GDH activity was increased during the late log and stationary phases of growth with the strain E. coli BL21(DE3)pLysS/dhaD, which was much higher than E. coli BL21(DE3)pLysS. Furthermore, the recombinant strain BL21(DE3)pLysS/dhaD exhibited the highest enzyme activity at a pH 7.0 (Fig. 5d).
Gene expression by RT-PCR analysis
However, for determining the expressions of the GDH gene in E. coli BL21(DE3)pLysS, E. coli BL21(DE3)pLysS/dhaD and K. pneumoniae SRP2 strains, qRT-PCR analysis was performed. qRT-PCR analysis was performed on bacteria having undergone glycerol transformation by the dhaD gene expression construct, which was obtained from K. pneumoniae SRP2. The use of two antibiotics (ampicillin, chloramphenicol) allowed the stable maintenance of plasmid in the recombinant bacterium. qRT-PCR analysis exhibited the expression of the dhaD gene from K. pneumoniae after the addition of IPTG as an inducer (Fig. 6). As gene expression often varied significantly in different growth phases (Quintero et al. 2009), all bacterial cells used for RNA isolation were cultured for a constant period to minimize its effect on RT-PCR analysis. It was undoubtedly observed that the transcription level of the GDH gene in E. coli BL21(DE3) pLysS/dhaD was much higher than that of the control strain E. coli BL21(DE3)pLysS (Fig. 6). In E. coli BL21(DE3)pLysS/dhaD, the expression level of the GDH gene was about 84 times more abundant than that in E. coli BL21(DE3)pLysS after 3 h of IPTG induction, due to GDH overexpression. Therefore, the results confirmed the expression of dhaD in the E. coli BL21(DE3)pLysS/dhaD expression system.
Overexpression of the pJET1.2/blunt-dhaD construct
The E. coli BL21(DE3)pLysS strain contained a fragment of the DE3 phage genome in the genome system has a T7 RNA polymerase gene under the control of the lacUV5 promoter. Logically, the bacterium contains the lacI gene in the chromosome and expression plasmid, which encodes a repressor that binds to the T7lac promoter on the expression plasmid and the lacUV5 operator–promoter, thereby blocking the expression of the gene encoding RNA polymerase. This repression is induced by IPTG which allows induced transcription from the T7lac promoter (ThermoFisher Scientific 2010). The gene dhaD was transcribed in a similar way and controlled by the T7lac promoter. The results indicate efficient overexpression of the dhaD gene from K. pneumoniae SRP2 in E. coli BL21(DE3)pLysS (Fig. 6). SDS-PAGE analysis of the expression products from genes inserted into the pJET1.2/blunt-dhaD construct indicates a higher level of the expressed protein in E. coli BL21(DE3)pLysS strain (Fig. 7). As shown in Fig. 7, the sample showed a protein brand of about 41 kDa, which is the GDH enzyme.
Batch fermentation by the recombinant E. coli BL21(DE3)pLysS/dhaD strain
The transformed E. coli BL21(DE3)pLysS/dhaD strain was used for biotransformation of glycerol to 2,3-BD. The time course data for the metabolic product, glycerol consumed and cell growth of batch cultivation at 37 °C by E. coli BL21(DE3)pLysS, E. coli BL21(DE3)pLysS/dhaD and K. pneumoniae SRP2 is presented in Fig. 8. The purpose of the culture was both to assess the production of 2,3-BD, glycerol consumption, the efficiency and selectivity of the process. The concentrations of the desired metabolite (2,3-BD) as well as of unused glycerol in the culture medium were analyzed using GC–FID. IPTG was added to the culture medium (MS-2 medium supplemented with 25.0 g/L glycerol) after 6 h. As the GDH activity was increased when the GDH gene was overexpressed, a study of the time course of glycerol metabolism by recombinant E. coli BL21(DE3)pLysS/dhaD, non-recombinant E. coli BL21(DE3)pLysS as well as the wild-type strain K. pneumoniae SRP2 was carried out in shake flasks. The recombinant bacterial strain E. coli BL21(DE3)pLysS/dhaD exhibited 8.97 g/L of 2,3-BD using 24.67 g/L of glycerol after 48 h incubation. This product yield of 2,3-BD is not as high as that of strain K. pneumoniae SRP2 reported in our earlier study (Rahman et al. 2015). The strain E. coli BL21(DE3)pLysS/dhaD might produce metabolic products including 1,3-PDO, ethanol, acetate, succinate or lactate with 2,3-BD (Xu et al. 2014). Therefore, the other two important genes, budB and budC, responsible for 2,3-BD production should be inserted into the glycerol metabolism pathway of E. coli BL21(DE3)pLysS/dhaD stain to get a high yield of 2,3-BD. Although there is no report on the pathway of 2,3-BD production in E. coli, several works have been done on systematic metabolic engineering of E. coli for high product yield of 2,3-BD by introducing budB and budC genes (Xu et al. 2014; Chu et al. 2015).
We have demonstrated that overexpression of GDH in a E. coli strain led to a significant improvement of GDH activity and 2,3-BD production. The increased GDH activity led to a 2.4-fold increase in 2,3-BD product yield compared with E. coli BL21(DE3)pLysS in a batch biotransformation when 25.0 g/L glycerol was supplied and the reaction time was shortened (Figs. 5a, 8). It is also possible that higher levels of GDH could increase the tolerance of the strain against product(s) inhibition, as suggested by Gätgens et al. (2007). Since in utilized a sufficient amount of glycerol, a relatively low yield of 2,3-BD was attained (Fig. 8a, b), possibly the recombinant strain produced bioproducts other than 2,3-BD due to lack of sufficient activities of other genes in the metabolic pathway of 2,3-BD. Therefore, further improvements in yield will have to construct recombinant strain by introducing budB and budC genes from highly efficient strain, and involve changes in fermentation procedures such as those described by Hekmat et al. (2003) who designed a reactor system consisting of a shaking tank and a permeable column harboring immobilized cells.
The current experiments were carried out with pure glycerol. In a commercial setting, most likely biodiesel-derived glycerol would have to be used. This type of glycerol typically contains various impurities that could cause severe inhibition at high concentrations, or even be toxic to the cells (Sabourin-Provost and Hallenbeck 2009). It remains to be determined if our recombinant strain will be able to provide high yields under those conditions.
A promising strain for industrial production of 2,3-BD was developed by overexpressing the GDH gene in the E. coli BL21(DE3)pLysS strain. Taking advantage of the elevated activity of GDH, the recombinant E. coli BL21(DE3)pLysS/dhaD strain can produce 2,3-BD at an acceptable concentration and display a substantially increased GDH activity when the IPTG inducer is used. The recombinant strain thus has potential for industrial production of 2,3-BD. From these results, the first reported dhaD expression system has paved the way for improvement of 2,3-BD production and is efficient for another heterologous gene expression in E. coli. For further improvement in yield, the recombinant strain could be constructed by introducing budB and budC genes in addition to the dhaD gene from a highly efficient strain.
Ahrens K, Menzel K, Zeng A, Deckwer W (1998) Kinetic, dynamic, and pathway studies of glycerol metabolism by Klebsiella pneumoniae in anaerobic continuous culture: III. Enzymes and fluxes of glycerol dissimilation and 1,3-propanediol formation. Biotechnol Bioeng 59(5):544–552
Atsumi S, Cann AF, Connor MR, Shen CR, Smith KM, Brynildsen MP, Chou KJ, Hanai T, Liao JC (2008) Metabolic engineering of Escherichia coli for 1-butanol production. Metab Eng 10:305–311
Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K (1987) Current protocols in molecular microbiology. Wiley, New York
Baez A, Cho KM, Liao JC (2011) High-flux isobutanol production using engineered Escherichia coli: a bioreactor study with in situ product removal. Appl Microbiol Biotechnol 90:1681–1690
Bokinsky G, Peralta-Yahya PP, George A, Holmes BM, Steen EJ, Dietrich J, Lee TS, Tullman D, Voigt CA, Simmons BA, Keasling JD (2011) Synthesis of three advanced biofuels from ionic liquid-pretreated switchgrass using engineered Escherichia coli. Proc Natl Acad Sci USA 108:19949–19954
Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254
Celińska E, Grajek W (2009) Biotechnological production of 2,3-butanediol—current state and prospects. Biotechnol Adv 27:715–725
Chart H, Smith HR, La Ragione RM, Woodward MJ (2000) An investigation into the pathogenic properties of Escherichia coli strains BLR, BL21, DH5alpha and EQ1. J Appl Microbiol 89:1048–1058
Chu H, Xin B, Liu P, Wang Y, Li L, Liu X (2015) Metabolic engineering of Escherichia coli for production of (2S,3S)-butane-2,3-diol from glucose. Biotech Biofuel 8:143
Domínguez de María P (2011) Recent developments in the biotechnological production of hydrocarbons: paving the way for bio-based platform chemicals. ChemSusChem 4:327–329
Gätgens C, Degner U, Meyer SB, Herrmann U (2007) Biotransformation of glycerol to dihydroxyacetone by recombinant Gluconobacter oxydans DSM 2343. Appl Microbiol Biotechnol 76:553–559
Gross M (2012) Looking for alternative energy sources. Curr Biol 22:R103–R106
Hekmat D, Bauer R, Fricke J (2003) Optimization of the microbial synthesis of dihydroxyacetone from glycerol with Gluconobacter oxydans. Bioprocess Biosyst Eng 26:109–116
Ji XJ, Huang H, Ouyang PK (2011) Microbial 2,3-butanediol production: a state-of-the-art review. Biotechnol Adv 29:351–364
Kim SJ, Seo SO, Jin YS, Seo JH (2013) Production of 2,3-butanediol by engineered Saccharomyces cerevisiae. Bioresour Technol 146:274–281
Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680–685
Li L, Wang Y, Zhang L, Ma C, Wang A, Tao F, Xu P (2012) Biocatalytic production of (2S,3S)-2,3-butanediol from diacetyl using whole cells of engineered Escherichia coli. Bioresour Technol 115:111–116
Li L, Li K, Wang Y, Chen C, Xu Y, Zhang L, Han B, Gao C, Tao F, Ma C, Xu P (2015) Metabolic engineering of Enterobacter cloacae for high-yield production of enantiopure (2R,3R)-2,3-butanediol from lignocellulose-derived sugars. Metab Eng 28:19–27
Lian J, Chao R, Zhao H (2014) Metabolic engineering of a Saccharomyces cerevisiae strain capable of simultaneously utilizing glucose and galactose to produce enantiopure (2R,3R)-butanediol. Metab Eng 23:92–99
Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real time quantitative PCR and 2−ΔΔCT method. Methods 25:402–408
May A, Fischer RJ, Thum SM, Schaffer S, Verseck S, Peter DP, Bahl H (2013) A modified pathway for the production of acetone in Escherichia coli. Metab Eng 15:218–225
Merfort M, Herrmann U, Ha SW, Elfari M, Bringer-Meyer S, Görisch H, Sahm H (2006) Modification of the membrane-bound glucose oxidation system in Gluconobacter oxydans significantly increases gluconate and 5-keto-d-gluconic acid accumulation. Biotechnol J 1:556–563
Oliver JW, Machado IM, Yoneda H, Atsumi S (2013) Cyanobacterial conversion of carbon dioxide to 2,3-butanediol. Proc Natl Acad Sci 110:1249–1254
Quintero Y, Poblet M, Guillamón JM, Mas A (2009) Quantification of the expression of reference and alcohol dehydrogenase genes of some acetic acid bacteria in different growth conditions. J Appl Microbiol 106:666–674
Rahman MS, Xu C, Ma K, Nanda M, Qin W (2015) High production of 2,3-butanediol by a mutant strain of the newly isolated Klebsiella pneumoniae SRP2 with increased tolerance towards glycerol. Int J Biol Sci 13:308–318
Sabourin-Provost G, Hallenbeck PC (2009) High yield conversion of a crude glycerol fraction from biodiesel production to hydrogen by photofermentation. Bioresour Technol 100:3513–3517
ThermoFisher Scientific (2010) One Shot BL21(DE3)plysS: Manual and Protocol. https://assets.thermofisher.com/TFS-Assets/LSG/manuals/oneshotbl21_man.pdf. Accessed 6 Dec 2017
Wang Q, Chen T, Zhao X, Chamu J (2012) Metabolic engineering of thermophilic Bacillus licheniformis for chiral pure d-2,3-butanediol production. Biotechnol Bioeng 109:1610–1621
Xiao Z, Wang X, Huang Y, Huo F, Zhu X, Xi L, Lu JR (2012) Thermophilic fermentation of acetoin and 2,3-butanediol by a novel Geobacillus strain. Biotechnol Biofuels 5:88–93
Xu H, Davies J, Miao V (2007) Molecular characterization of class 3 integrons from Delftia spp. J Bacteriol 189:6276–6283
Xu Y, Chu H, Dao C, Tao F, Zhou Z et al (2014) Systematic metabolic engineering of Escherichia coli for high-yield production of fuel bio-chemical 2,3-butanediol. Metab Eng 23:22–33
Yan Y, Lee CC, Liao JC (2009) Enantioselective synthesis of pure (R, R)-2,3-butanediol in Escherichia coli with stereospecific secondary alcohol dehydrogenases. Org Biomol Chem 7:3914–3917
Yang J, Nie Q, Ren M, Feng H, Jiang X, Zheng Y, Liu M, Zhang H, Xian M (2013) Metabolic engineering of Escherichia coli for the biosynthesis of alphapinene. Biotechnol Biofuels 6:60–66
Zeng AP, Sabra W (2011) Microbial production of diols as platform chemicals: recent progresses. Curr Opin Biotechnol 22:749–757
Zhang L, Xu Q, Zhan S, Li Y, Lin H, Sun S, Sha L, Hu K, Guan X, Shen Y (2013) A new NAD(H)-dependent meso-2,3-butanediol dehydrogenase from an industrially potential strain Serratia marcescens H30. Appl Microbiol Biotechnol 98(3):1175–1184
Provided the research idea and designed the experiments: MSR, CX and WQ. Performed the experiments and analyzed the data: MSR. Wrote the paper: MSR. Edited: QW. All authors read and approved the final manuscript.
Acknowledgements and funding
This work was supported by the Grant of BioFuelNet Canada (Project No. 67) and Lakehead University.
The authors declare that they have no competing interests.
Availability of data and materials
All data generated or analyzed during this study are included in this article.
Consent for publication
All authors provided consent for publishing the manuscript to Bioresources and Bioprocessing.
Ethics approval and consent to participate
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.